Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 19 Categorisation of clinical trials of medicinal products

1 Clin­ic­al tri­als of medi­cin­al products come un­der Cat­egory A if the medi­cin­al product is au­thor­ised in Switzer­land and its use:

a.
is in ac­cord­ance with the pre­scrib­ing in­form­a­tion;
b.
is in an in­dic­a­tion or dosage dif­fer­ent from that spe­cified in the pre­scrib­ing in­form­a­tion, but in ac­cord­ance with the fol­low­ing cri­ter­ia:
1.
the in­dic­a­tion is with­in the same dis­ease group of the In­ter­na­tion­al Clas­si­fic­a­tion of Dis­eases (ICD), as spe­cified in An­nex 1 num­ber 3,
2.
the dis­ease in ques­tion is self-lim­it­ing and the dosage of the medi­cin­al product is lower than that spe­cified in the pre­scrib­ing in­form­a­tion; or
c.
is re­cog­nised as stand­ard in guidelines pre­pared in ac­cord­ance with in­ter­na­tion­ally ac­cep­ted qual­ity cri­ter­ia.

2 Clin­ic­al tri­als of medi­cin­al products come un­der Cat­egory B if the medi­cin­al product:

a.
is au­thor­ised in Switzer­land; and
b.
is not used as spe­cified in para­graph 1.

3 They come un­der Cat­egory C if the medi­cin­al product is not au­thor­ised in Switzer­land.

4 In jus­ti­fied cases, a clin­ic­al tri­al of a medi­cin­al product au­thor­ised in Switzer­land may be as­signed to a dif­fer­ent cat­egory if this is pos­sible or ne­ces­sary with re­gard to medi­cin­al product safety or pro­tec­tion of the par­ti­cipants’ safety and health.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden